Greater curability in advanced Hodgkin's disease?

Portlock, C S

Portlock, C S.

Affiliation

Portlock CS; Memorial Sloan-Kettering Cancer Center, New York, NY 10021-6007, USA.

Cancer J Sci Am ; 5(5): 264-5, 1999.

Article in En | MEDLINE | ID: mdl-10526665

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Hodgkin Disease/drug therapy; Hodgkin Disease/mortality; Bleomycin/therapeutic use; Combined Modality Therapy; Cyclophosphamide/therapeutic use; Dacarbazine/therapeutic use; Doxorubicin/therapeutic use; Epirubicin/therapeutic use; Etoposide/therapeutic use; Hodgkin Disease/radiotherapy; Humans; Mechlorethamine/therapeutic use; Prednisone/therapeutic use; Procarbazine/therapeutic use; Remission Induction; Vinblastine/therapeutic use; Vincristine/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols Limits: Humans Language: En Journal: Cancer J Sci Am Year: 1999 Document type: Article

Search on Google

XML

PubMed Links